(Q34975873)

5 August 2017

title

Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity (English)

1 reference

5 August 2017

1 reference

K M Giezeman

1

1 reference

5 August 2017

J Nauta

series ordinal

2

1 reference

5 August 2017

I A de Bruijn

series ordinal

3

1 reference

5 August 2017

A M Palache

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

12 February 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

27

1 reference

5 August 2017

issue

18

1 reference

5 August 2017

page(s)

2414-2417

1 reference

Influenza vaccines. A reappraisal of their use.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Cost-effectiveness of influenza vaccination of healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Influenza Vaccination in Children with Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Influenza vaccination in asthmatic children: effects on quality of life and symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

The underrecognized burden of influenza in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

The global agenda on influenza surveillance and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.008

10.1016/J.VACCINE.2009.02.008

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference